BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11996960)

  • 1. Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD.
    Yokota H; Hashimoto Y; Okubo S; Yumoto M; Mashige F; Kawamura M; Kotani K; Usuki Y; Shimada S; Kitamura K; Nakahara K
    Atherosclerosis; 2002 Jun; 162(2):399-407. PubMed ID: 11996960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
    Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
    J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
    Miccoli R; Bertolotto A; Navalesi R; Odoguardi L; Boni A; Wessling J; Funke H; Wiebusch H; Eckardstein A; Assmann G
    Circulation; 1996 Oct; 94(7):1622-8. PubMed ID: 8840853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
    Ng DS; Leiter LA; Vezina C; Connelly PW; Hegele RA
    J Clin Invest; 1994 Jan; 93(1):223-9. PubMed ID: 8282791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cysteine-containing truncated apo A-I variant associated with HDL deficiency.
    Moriyama K; Sasaki J; Takada Y; Matsunaga A; Fukui J; Albers JJ; Arakawa K
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1416-23. PubMed ID: 8977444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
    Bruckert E; von Eckardstein A; Funke H; Beucler I; Wiebusch H; Turpin G; Assmann G
    Atherosclerosis; 1997 Jan; 128(1):121-8. PubMed ID: 9051205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
    Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
    Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypobetalipoproteinemia associated with apo B-48.4, a truncated protein only 14 amino acids longer than apo B-48.
    Ruotolo G; Zanelli T; Tettamanti C; Ragogna F; Parlavecchia M; Viganò F; Catapano AL
    Atherosclerosis; 1998 Mar; 137(1):125-31. PubMed ID: 9568744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).
    Wada M; Iso T; Asztalos BF; Takama N; Nakajima T; Seta Y; Kaneko K; Taniguchi Y; Kobayashi H; Nakajima K; Schaefer EJ; Kurabayashi M
    Atherosclerosis; 2009 Nov; 207(1):157-61. PubMed ID: 19473658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel truncated apolipoprotein B (apo B55) in a patient with familial hypobetalipoproteinemia and atypical retinitis pigmentosa.
    Talmud PJ; Converse C; Krul E; Huq L; McIlwaine GG; Series JJ; Boyd P; Schonfeld G; Dunning A; Humphries S
    Clin Genet; 1992 Aug; 42(2):62-70. PubMed ID: 1424233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
    Manfroi WC; Zago AJ; Campos M; Alves A; Brisolara ML; de Souza J; Candiago RH; Kirschnick L; Ribeiro L; Ordovás K; Leitão C; Cruz R
    Arq Bras Cardiol; 1999 Jun; 72(6):657-68. PubMed ID: 10752172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease.
    Takata K; Saku K; Ohta T; Takata M; Bai H; Jimi S; Liu R; Sato H; Kajiyama G; Arakawa K
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1866-74. PubMed ID: 7583566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.
    Huang W; Sasaki J; Matsunaga A; Nanimatsu H; Moriyama K; Han H; Kugi M; Koga T; Yamaguchi K; Arakawa K
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):389-96. PubMed ID: 9514407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.